REGENCY Dandy for Roche In Lupus Nephritis

Gazyva could add the autoimmune condition to its label following a Phase III hit, but it might struggle to differentiate itself from Benlysta and Lupkynis.    

Blue and purple graphic image of pair of kidneys
• Source: Shutterstock

More from Clinical Trials

More from R&D